Showing results (631-640 of 2,065) with videos related to
Sort By:
Pageof 207
International Journal of Pharmaceutics|August 30, 2011
Production and characterization of antioxidant apigenin nanocrystals as a novel UV skin protective formulationLoaye Al Shaal, Ranjita Shegokar, Rainer H MüllerMycoses|December 23, 1998
Therapy of sinuorbital aspergillosis with amphotericin B colloidal dispersionK Rieske, W Handrick, H Müller, et al.Journal of Microencapsulation|January 13, 2006
A novel approach based on lipid nanoparticles (SLN) for topical delivery of alpha-lipoic acidE B Souto, R H Müller, S GohlaArchives of Gynecology and Obstetrics|January 1, 1996
Serum placental protein 14 (PP14) levels in patients with threatened abortionS Tomczak, V Briese, S Kunkel, et al.Neuropsychobiology|January 1, 1995
Are there any differences in the safety and efficacy of brofaromine and imipramine between non-elderly and elderly patients with major depression?H P Volz, H Müller, H J MöllerThe Journal of Cell Biology|September 1, 1992
Sec8p and Sec15p are components of a plasma membrane-associated 19.5S particle that may function downstream of Sec4p to control exocytosisR Bowser, H Müller, B Govindan, et al.Yeast (Chichester, England)|July 1, 1992
SEC6 encodes an 85 kDa soluble protein required for exocytosis in yeastM Potenza, R Bowser, H Müller, et al.Der Nervenarzt|June 5, 2004
[Long-term treatment of phantom- and stump pain with Botulinum toxin type A over 12 months. A first clinical observation]U Kern, C Martin, S Scheicher, et al.Neuron|May 1, 1993
Inhibition of high voltage-activated calcium currents by L-glutamate receptor-mediated calcium influxH U Zeilhofer, T H Müller, D SwandullaCardiology Clinics|August 1, 1994
Pharmacology of current and future antithrombotic therapiesT H Müller, K Binder, B D GuthPageof 207